Featured Video: Liver Cancer Awareness Month

Hepatocellular carcinoma (HCC), also referred to as primary liver cancer, has the highest rate of rise among cancers in the United States.

The greatest obstacle to improving patient survival remains the inability to find patients in need of routine liver cancer screening, a liver imaging study and blood test called an “Alpha Fetal Protein” (AFP) every 6-12 months.

Appropriate liver imaging studies are: 1) an ultrasound of the liver or 2) a triple phase contrast CAT scan or MRI. The blood test used to detect liver cancer is an alpha fetal protein, which will be abnormally high in 70-80% of patients with a liver cancer.